1. Analysis of non‐responders to dupilumab in clinical practice: a cohort study. (9th October 2020) Authors: Linder, C.; Shourick, J.; Touhouche, A.T; Giordano‐Labadie, F.; Severino‐Freire, M.; Borjesson, C.; Richet, C.; Marguery, M.C.; Tauber, M.; Paul, C. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 35:Number 3(2021) Page Start: e192 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effect of dupilumab on atopic manifestations in patients treated for atopic dermatitis in real‐life practice. (1st June 2019) Authors: Tauber, M.; Apoil, P.A.; Richet, C.; Laurent, J.; De Bonnecaze, G.; Mouchon, E.; Cassagne, M.; Marguery, M.C.; Hegazy, S.; Konstantinou, M.P.; Severino, M.; Uthurriague, C.; Giordano‐Labadie, F.; Didier, A.; Paul, C. Journal: British journal of dermatology Issue: Volume 180:Number 6(2019) Page Start: 1551 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effect of dupilumab on atopic manifestations in patients treated for atopic dermatitis in real‐life practice. (27th March 2019) Authors: Tauber, M.; Apoil, P.A.; Richet, C.; Laurent, J.; De Bonnecaze, G.; Mouchon, E.; Cassagne, M.; Marguery, M.C.; Hegazy, S.; Konstantinou, M.P.; Severino, M.; Uthurriague, C.; Giordano‐Labadie, F.; Didier, A.; Paul, C. Journal: British journal of dermatology Issue: Volume 180:Number 6(2019) Page Start: 1551 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗